Changes

Volunteer Assignments and Opportunities (view source)

Revision as of 10:12, 8 July 2020

71 bytes added , 10:12, 8 July 2020

no edit summary

Line 8: Line 8:

!Notes

|-

−

|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera

+

|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera

|Fabiola Quintero-Rivera (FQR)

|PENDING

Line 15: Line 15:

|-

| Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease

−

|Mark Evans+Jack Reid+Fabiola Quintero-Rivera

+

|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera

|FQR

|PENDING

Line 55: Line 55:

|-

| Myeloproliferative Neoplasm (MPN), Unclassifiable||Disease

−

|Mark Evans+ Fabiola Quintero-Rivera

+

|Mark Evans (trainee)+ Fabiola Quintero-Rivera

|FQR

|PENDING

Line 157: Line 157:

|

|-

−

| Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu+Fabiola Quintero-Rivera

+

| Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera

|FQR

|PENDING

Line 865: Line 865:

|

|-

−

|Plasmablastic Lymphoma||Disease||Mark Evans, Fabiola Quintero-Rivera||GC

+

|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera||GC

|Complete

|

Line 1,185: Line 1,185:

|

|-

−

| Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease||''~~Anna Shestakova~~,''

+

| Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''

Fabiola Quintero-Rivera

Jennelleh

Bureaucrats, Editors, Administrators

3,883

edits